Dr. Klos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7134 S Yale Ave
Ste 205
Tulsa, OK 74136Phone+1 918-392-4530Fax+1 918-392-4535
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2001 - 2004
University of Virginia Medical CenterInternship, Internal Medicine, 2000 - 2001
University of Oklahoma College of MedicineClass of 2000
Certifications & Licensure
OK State Medical License 2005 - 2025
KS State Medical License 2013 - 2016
MN State Medical License 2001 - 2006- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 17 citationsSafety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.Andrew McGarry, Shane Rosanbalm, Mika Leinonen, C Warren Olanow, Dennis To
The Lancet. Neurology. 2024-01-01 - 8 citationsUlotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HTAgonist, in Patients With Parkinson Disease Psychosis: A Pilot Study.Stuart H Isaacson, Mark Goldstein, Rajesh Pahwa, Carlos Singer, Kevin Klos
Neurology. Clinical Practice. 2023-08-01 - 21 citationsOral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.Michael Camilleri, Thyagarajan Subramanian, Fernando Pagan, Stuart Isaacson, Ramon Gil
Annals of Internal Medicine. 2022-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
